SciELO - Scientific Electronic Library Online

 
vol.17 issue2ENFERMEDAD TROMBOEMBÓLICA VENOSA: ¿UNA PATOLOGÍA FRECUENTE POCO RECONOCIDA?PRIMARY BILIARY CIRRHOSIS - AUTOIMMUNE HEPATITIS OVERLAP SYNDROME. CONTRIBUTION OF NEW CASE author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Médica La Paz

On-line version ISSN 1726-8958

Abstract

RUIZ DOMINGUEZ, Rosario; ALVAREZ L., Julio  and  ESCOBAR G., Gretel. HOW MUCH DO WE KNOW THE DOCTORS ABOUT BLOOD AND BLOOD DERIVATIVES TRANSFUSION?. Rev. Méd. La Paz [online]. 2011, vol.17, n.2, pp.21-28. ISSN 1726-8958.

We analyzed the knowledge of general and specialists doctors from the Caja Nacional de Salud, about indications, benefits and risks of blood transfusions and blood derivatives before the implementation of the new blood transfusion application form or blood derivatives of the National Blood Program and the Caja Nacional de Salud. We distributed 207 self applied enquiries to general and specialist medics from different hospitals and medical centers from the Caja Nacional de Salud, the enquiries included 8 questions extracted from the last paragraph of the new blood transfusion application form; 141 enquires were included by criteriain the study; 90.8% of professionals expected to find clinical improvement with transfusion, 99.3% know the transmission of infection risks through these, 92.9% evaluated benefits and risks before commanding the blood transfusion, 66.6% of register in the clinical history the reasons for the indication, however, there is a few knowledge about the therapeutic alternatives before transfuse and the blood transfusion indications are not uniform. The transfusion-saving strategy has to begin with the training of medical personnel related to indications, the development of a adequate user manual of blood derivatives and stimulants haematinics and folates use protocols in preoperative rescue cases, ferropenic, megaloblastic anemias and the creation hemosurveillance committee in accordance with the policies of the National Blood Program.

Keywords : transfusion therapy; transfusional risks; therapeutic alternatives.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License